Avience Biomedicals Limited Peer Comparison
The Avience Biomedicals IPO is a book build issue with a total issue size of ₹30 cr, comprising of fresh issue of 1371600 equity shares. Avience Biomedicals IPO opened for subscription on Jun 18, 2026 and closed on Jun 22, 2026. Avience Biomedicals IPO is set price band at ₹196 to ₹208 per share, with a lot size of 600 shares. Minimum investment for Retail investors was ₹249,600.00 (at the upper price band) to apply for one lot.
The basis of allotment got finalized on Jun 23, 2026, and listed on the NSE on Jun 25, 2026.
Skyline Financial Services Private Ltd has been appointed as the registrar. Fintellectual Corporate Advisors Private Limited are the Book Running Lead Manager for the issue.
Before investing in the Avience Biomedicals IPO, investors should review the company's financial performance, business objectives, and risk factors mentioned in the offer documents and apply before the subscription window closes.
*Info is indicative. Not an Investment Advice. Grey market trading is unregulated.
Avience Biomedicals Limited Peer Comparision
No Peer Comparision Available
Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
Avience Biomedicals IPO is a Book-building IPO with a total issue size of ₹30 crore. The Avience Biomedicals IPO price band is ₹196 to 208 per share. The Avience Biomedicals IPO subscription opens on Thu, Jun 18, 2026, and closes on Mon, Jun 22, 2026. The Avience Biomedicals IPO will be listed on the NSE. Skyline Financial Services Private Ltd is the registrar for the Avience Biomedicals IPO.
The Avience Biomedicals IPO opens on Thu, Jun 18, 2026 and closes on Mon, Jun 22, 2026
Avience Biomedicals IPO Price Band is ₹196 to 208 per share.
Avience Biomedicals IPO lot size is 600 shares, Retail investors need a minimum investment of ₹249600 based on the upper price band
The minimum investment for Avience Biomedicals IPO is ₹249600, based on one lot of 600 shares at the upper price band of ₹208 per share.
Investors can apply for the Avience Biomedicals IPO through the ASBA (Application Supported by Blocked Amount) facility offered by their bank or through UPI using a SEBI-registered broker or trading app. Select the desired lot size, enter your bid within the price band, and submit the application before Mon, Jun 22, 2026. The application amount remains blocked until the Avience Biomedicals IPO allotment is finalized.
Avience Biomedicals IPO issue size is ₹30 crores.
Avience Biomedicals IPO allotment date is Wed, Jul 1, 2026.
The registrar for Avience Biomedicals IPO is Skyline Financial Services Private Ltd. Investors can go to Skyline Financial Services Private Ltd website to check Avience Biomedicals IPO allotment status, refund processing, and other IPO-related information.
The Avience Biomedicals IPO GMP (Grey Market Premium) is ₹145 as of Thu, Jun 25, 2026. Based on the upper price band of ₹208 per share, the estimated Avience Biomedicals IPO listing price is ₹353, indicating a potential listing gain of approximately 0% over the issue price.